GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Co Ltd (ROCO:6892) » Definitions » EV-to-Revenue

Taiwan Bio Therapeutics Co (ROCO:6892) EV-to-Revenue : 29.20 (As of Oct. 31, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Taiwan Bio Therapeutics Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Taiwan Bio Therapeutics Co's enterprise value is NT$2,943.2 Mil. Taiwan Bio Therapeutics Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was NT$100.8 Mil. Therefore, Taiwan Bio Therapeutics Co's EV-to-Revenue for today is 29.20.

The historical rank and industry rank for Taiwan Bio Therapeutics Co's EV-to-Revenue or its related term are showing as below:

ROCO:6892' s EV-to-Revenue Range Over the Past 10 Years
Min: 22.71   Med: 36.99   Max: 55.07
Current: 29.2

During the past 5 years, the highest EV-to-Revenue of Taiwan Bio Therapeutics Co was 55.07. The lowest was 22.71. And the median was 36.99.

ROCO:6892's EV-to-Revenue is ranked worse than
71.64% of 1033 companies
in the Biotechnology industry
Industry Median: 8.14 vs ROCO:6892: 29.20

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-10-31), Taiwan Bio Therapeutics Co's stock price is NT$41.80. Taiwan Bio Therapeutics Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was NT$1.57. Therefore, Taiwan Bio Therapeutics Co's PS Ratio for today is 26.57.


Taiwan Bio Therapeutics Co EV-to-Revenue Historical Data

The historical data trend for Taiwan Bio Therapeutics Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Bio Therapeutics Co EV-to-Revenue Chart

Taiwan Bio Therapeutics Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
- - - 37.53 24.92

Taiwan Bio Therapeutics Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only - 37.53 - 24.92 -

Competitive Comparison of Taiwan Bio Therapeutics Co's EV-to-Revenue

For the Biotechnology subindustry, Taiwan Bio Therapeutics Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiwan Bio Therapeutics Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Taiwan Bio Therapeutics Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Taiwan Bio Therapeutics Co's EV-to-Revenue falls into.



Taiwan Bio Therapeutics Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Taiwan Bio Therapeutics Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2943.205/100.802
=29.20

Taiwan Bio Therapeutics Co's current Enterprise Value is NT$2,943.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Taiwan Bio Therapeutics Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was NT$100.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taiwan Bio Therapeutics Co  (ROCO:6892) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Taiwan Bio Therapeutics Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=41.80/1.573
=26.57

Taiwan Bio Therapeutics Co's share price for today is NT$41.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2024 was NT$1.57.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taiwan Bio Therapeutics Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Taiwan Bio Therapeutics Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiwan Bio Therapeutics Co Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Lane 120, Hu Road, Section 1, 6th Floor, Neihu District, Taipei, TWN
Taiwan Bio Therapeutics Co Ltd is a regenerative medicine company specializing in the development of new cell medicines. It provides cell product process development and foundry (CDMO/CMO) services.

Taiwan Bio Therapeutics Co Headlines

No Headlines